The Optimizing Psilocybin Study (OPT-IN) – Vail, Colorado
Through the establishment of The Vail Health Behavioral Health Innovation Center (BHIC), a collaboration between Vail Health and University of Wisconsin-Madison directed by Dr. Charles Raison, our research team will support the implementation of the OPT-IN Study which will examine novel ways to enhance the impact of psilocybin on depression and anxiety via co-administration of non-invasive vagus nerve stimulation.
To be conducted at the Vail Health BHIC, this study is unique in that it will also assess the impact of psilocybin on real-world social behavior and will use advanced strategies to better understand the risks and benefits of psilocybin use in a legalized setting, such as Colorado.